相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Rhabdoid Tumor Predisposition Syndrome: From Clinical Suspicion to General Management
Giada Del Baldo et al.
FRONTIERS IN ONCOLOGY (2021)
Efficacy of MEK inhibition in a recurrent malignant peripheral nerve sheath tumor
Sumanth Nagabushan et al.
NPJ PRECISION ONCOLOGY (2021)
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation
Eric Legius et al.
GENETICS IN MEDICINE (2021)
A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective study
Sheri L. Spunt et al.
LANCET ONCOLOGY (2020)
The Risk of Peripheral Nerve Tumor Biopsy in Suspected Benign Etiologies
Roberto J. Perez-Roman et al.
NEUROSURGERY (2020)
New Frontiers in Therapy of Peripheral Nerve Sheath Tumors in Patients With Neurofibromatosis Type 1: Latest Evidence and Clinical Implications
Agata Marjanska et al.
ANTICANCER RESEARCH (2020)
The Use of MEK Inhibitors in Neurofibromatosis Type 1-Associated Tumors and Management of Toxicities
Laura J. Klesse et al.
ONCOLOGIST (2020)
Prognosis and risk factors for malignant peripheral nerve sheath tumor: a systematic review and meta-analysis
Zhenyu Cai et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2020)
Neurofibromin Structure, Functions and Regulation
Mohammed Bergoug et al.
CELLS (2020)
Diagnosis and management of malignant peripheral nerve sheath tumors: Current practice and future perspectives
Bethany C. Prudner et al.
NEURO-ONCOLOGY ADVANCES (2020)
Dramatic response to trametinib in a male child with neurofibromatosis type 1 and refractory astrocytoma
Tristan Knight et al.
PEDIATRIC BLOOD & CANCER (2019)
Radiation-induced and neurofibromatosis-associated malignant peripheral nerve sheath tumors (MPNST) have worse outcomes than sporadic MPNST
Ruoyu Miao et al.
RADIOTHERAPY AND ONCOLOGY (2019)
Oncologic Accuracy of Image-guided Percutaneous Core-Needle Biopsy of Peripheral Nerve Sheath Tumors at a High-volume Sarcoma Center
Danielle S. Graham et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2019)
TRK Fusion Cancers in Children: A Clinical Review and Recommendations for Screening
Catherine M. Albert et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Differentiation of peripheral nerve sheath tumors in patients with neurofibromatosis type 1 using diffusion-weighted magnetic resonance imaging
Lennart Well et al.
NEURO-ONCOLOGY (2019)
PET Imaging of Peripheral Nerve Tumors
Majid Assadi et al.
PET CLINICS (2019)
Monitoring of plexiform neurofibroma in children and adolescents with neurofibromatosis type 1 by [18F]FDG-PET imaging. Is it of value in asymptomatic patients?
Amedeo A. Azizi et al.
PEDIATRIC BLOOD & CANCER (2018)
Malignant Peripheral Nerve Sheath Tumors A Single Institution's Experience Using Combined Surgery and Radiation Therapy
Andrew J. Bishop et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2018)
Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis: Impact of Family History
Fatema Malbari et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2018)
Genomic Profiling in Patients With Malignant Peripheral Nerve Sheath Tumors Reveals Multiple Pathways With Targetable Mutations
Henry G. Kaplan et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)
Malignant peripheral nerve sheath tumors of the spine: results of surgical management from a multicenter study
Dean Chou et al.
JOURNAL OF NEUROSURGERY-SPINE (2017)
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial
Alessandro Gronchi et al.
LANCET ONCOLOGY (2017)
Does elevated glucose metabolism correlate with higher cell density in Neurofibromatosis type 1 associated peripheral nerve sheath tumors?
Dominik Berzaczy et al.
PLOS ONE (2017)
Methylation-based classification of benign and malignant peripheral nerve sheath tumors
Manuel Roehrich et al.
ACTA NEUROPATHOLOGICA (2016)
Malignant Peripheral Nerve Sheath Tumor Is a Challenging Diagnosis: A Systematic Pathology Review, Immunohistochemistry, and Molecular Analysis in 160 Patients From the French Sarcoma Group Database
Sophie Le Guellec et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group
A. Gronchi et al.
ANNALS OF ONCOLOGY (2016)
Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO)
T. Valentin et al.
EUROPEAN JOURNAL OF CANCER (2016)
A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma
Peter M. Anderson et al.
PEDIATRIC BLOOD & CANCER (2016)
Intraoperative high-resolution ultrasound and contrast-enhanced ultrasound of peripheral nerve tumors and tumorlike lesions
Maria Teresa Pedro et al.
NEUROSURGICAL FOCUS (2015)
Advances in Molecular Diagnosis of Neurofibromatosis Type 1
Ben Shofty et al.
SEMINARS IN PEDIATRIC NEUROLOGY (2015)
Conventional and Functional MR Imaging of Peripheral Nerve Sheath Tumors: Initial Experience
S. Demehri et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2014)
Benign whole body tumor volume is a risk factor for malignant peripheral nerve sheath tumors in neurofibromatosis type 1
Rosa Nguyen et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Pediatric and adult malignant peripheral nerve sheath tumors: an analysis of data from the surveillance, epidemiology, and end results program
E. Susan Amirian et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies
Thomas De Raedt et al.
NATURE (2014)
Utility of 18F-FDG PET with a Semi-Quantitative Index in the Detection of Sarcomatous Transformation in Patients with Neurofibromatosis Type 1
Patrick Combemale et al.
PLOS ONE (2014)
Radiation therapy in management of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors
Jenna Kahn et al.
FRONTIERS IN ONCOLOGY (2014)
Survival meta-analyses for > 1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1
Matthias Kolberg et al.
NEURO-ONCOLOGY (2013)
Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problems
Fausto J. Rodriguez et al.
ACTA NEUROPATHOLOGICA (2012)
Malignant Peripheral Nerve Sheath Tumors (MPNST): The Mayo Clinic Experience
Chee-Chee H. Stucky et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Phase II Study of Ganitumab, a Fully Human Anti-Type-1 Insulin-Like Growth Factor Receptor Antibody, in Patients With Metastatic Ewing Family Tumors or Desmoplastic Small Round Cell Tumors
William D. Tap et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC Soft Tissue and Bone Sarcoma Group study
J. R. Kroep et al.
ANNALS OF ONCOLOGY (2011)
Grading of Nonrhabdomyosarcoma Soft Tissue Sarcoma in Children and Adolescents A Comparison of Parameters Used for the Federation Nationale des Centers de Lutte Contre le Cancer and Pediatric Oncology Group Systems
Joseph D. Khoury et al.
CANCER (2010)
Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma.
Alice L. Yu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Differentiation between neurofibromas and malignant peripheral nerve sheath tumors in neurofibromatosis 1 evaluated by MRI
Akihiko Matsumine et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2009)
A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma
Nabeel Pervaiz et al.
CANCER (2008)
Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma
Ruth A. Kleinerman et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Second primary tumors in neurofibromatosis I patients treated for optic glioma: Substantial risks after radiotherapy
Saba Sharif et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Malignant peripheral nerve sheath tumors - Prognostic factors and survival in a series of patients treated at a single institution
Matteo Anghileri et al.
CANCER (2006)
Pediatric malignant peripheral nerve sheath tumor: The Italian and German soft tissue sarcoma cooperative group
M Carli et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Symptoms associated with malignancy of peripheral nerve sheath tumours:: a retrospective study of 69 patients with neurofibromatosis 1
L Valeyrie-Allanore et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
Synovial sarcoma: A retrospective analysis of 271 patients of all ages treated at a single institution
A Ferrari et al.
CANCER (2004)
Malignant peripheral nerve sheath tumor - The clinical spectrum and outcome of treatment
JM Baehring et al.
NEUROLOGY (2003)
Surgical margins and reresection in the management of patients with soft tissue sarcoma using conservative surgery and radiation therapy
GK Zagars et al.
CANCER (2003)
Clear cell sarcoma of tendons and aponeuroses in pediatric patients - A report from the Italian and German Soft Tissue Sarcoma Cooperative Group
A Ferrari et al.
CANCER (2002)
Neurofibromas in NF1: Schwann cell origin and role of tumor environment
Y Zhu et al.
SCIENCE (2002)
Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: Results of the Italian randomized cooperative trial
S Frustaci et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
分享论文
